Intravenous Ascorbic Acid as an Adjuvant Therapy for Recombinant Erythropoietin in Hemodialysis Patients With Hyperferritinemia

Kidney International - United States
doi 10.1046/j.1523-1755.1999.00479.x
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy